Table 1.

Demographic and neuropsychological data for all subjects

bvFTDsvPPAt tests
MSDnMSDntp
Age, time 1 (years)63.76.241561.07.55110.97>0.1
Education (years)16.23.081515.02.19111.16>0.1
Disease duration (years)3.72.18152.91.65111.07>0.1
FTLD-CDR SoB time 18.52.61138.72.9090.18>0.1
FTLD-CDR SoB time 210.23.471311.72.7891.13>0.1
MMSE time 1 (total = 30)25.42.731426.13.53110.57>0.1
MMSE time 2 (total = 30)24.34.071519.97.70100.87>0.1
Apathy time 1 (max = 3)2.01.10112.71.4191.16>0.1
Apathy time 2 (max = 3)1.40.97102.71.0092.80*0.012
Disinhibition time 1 (max = 3)2.20.75112.01.0090.45>0.1
Disinhibition time 2 (max = 3)1.80.92101.91.1790.18>0.1
Language time 1 (total = 19)15.52.79108.12.8485.51*0.001
Language time 2 (total = 19)14.13.687.04.2783.63*0.003
PPT time 1 (total = 26)23.91.86717.93.9873.61*0.006
PPT time 2 (total = 26)22.12.64817.03.5862.96*0.016
BNT time 1 (total = 30)24.53.6266.36.3445.21*0.005
BNT time 2 (total = 30)22.16.3886.34.3545.07*0.001
  • Mean (M), SD, sample size (n), t scores, and p values of comparisons. Asterisks indicate significant contrasts (p < 0.05). Mann–Whitney–Wilcoxon tests were used to confirm results of non-parametric data for disease duration, FTLD-CDR, MMSE, disinhibition, and language.